Top Sell
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.34 | €4.62 | 1251.170% |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.22 | €7.35 | 3211.532% |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.64 | €5.07 | 696.619% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Orasure Tech | 3 | 1 | 0 | 0 | €3.98 | €8.36 | 110.008% |
| Nevro Corp. | 3 | 3 | 0 | 1 | €9.10 | €21.13 | 132.249% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.82 | €5.51 | 573.333% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.38 | €50.00 | 3531.082% |
| Trevena Inc. | 2 | 20 | 0 | 2 | €0.18 | €6.48 | 3541.573% |
| Owens & Minor Inc. | 2 | 2 | 0 | 0 | €15.30 | €25.05 | 63.731% |
| Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Inventiva SA | 1 | 1 | 0 | 1 | €2.21 | €6.00 | 171.493% |
| Medigene AG | 1 | 1 | 0 | 0 | €1.15 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €1.07 | €2.00 | 87.617% |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.58 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.40 | - | - |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 3 | €2.92 | - | - |
| Organovo Holdings Inc. | 0 | 8 | 0 | 1 | €0.52 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.79 | €1.20 | -32.961% |
| Neptune Wellness Solutions Inc | 0 | 11 | 0 | 0 | €0.14 | - | - |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| T2 Biosystems Inc. | 0 | 6 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.26 | - | - |